|
Re: Received a response....Third Eye Loan Balance-Updated
|
2
|
Resverlogix Corp.
|
Jul 17, 2019 05:53AM
|
|
Re: Hedge Knight Capital Discussion
|
2
|
Resverlogix Corp.
|
May 26, 2019 07:38AM
|
|
Re: MERK
|
2
|
Resverlogix Corp.
|
Sep 30, 2021 08:46AM
|
|
Re: The waiting game.....
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 04:08PM
|
|
Re: Trading
|
2
|
Zenith Epigenetics
|
Sep 21, 2022 01:26PM
|
|
Re: Should we expect a synopsis from yesterday’s AGM?
|
2
|
Zenith Epigenetics
|
Oct 28, 2022 09:12AM
|
|
Re: Maybe So
|
2
|
Resverlogix Corp.
|
Aug 18, 2020 04:40PM
|
|
Re: Third Eye Loan
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 10:59AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
2
|
Resverlogix Corp.
|
May 17, 2022 01:12PM
|
|
Re: BOD AGM
|
2
|
Resverlogix Corp.
|
Jun 01, 2022 07:02AM
|
|
Re: No news
|
2
|
Resverlogix Corp.
|
Sep 17, 2022 06:19AM
|
|
Re: Can't you feel the excitment?
|
2
|
Resverlogix Corp.
|
Aug 16, 2019 11:07AM
|
|
Re: In regards to the share price and trading...
|
2
|
Resverlogix Corp.
|
Mar 19, 2021 10:35AM
|
|
RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
2
|
Resverlogix Corp.
|
Jun 22, 2022 04:38AM
|
|
News Alert
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 07, 2020 09:16AM
|
|
Re: Report Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Apr 21, 2024 05:44AM
|
|
Re: Next private placement/licensing agreement
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 02:40PM
|
|
Report of exempt distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Sep 10, 2022 06:34AM
|
|
Re: Idea for Zenith
|
2
|
Zenith Epigenetics
|
Jul 16, 2021 02:51PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
2
|
Resverlogix Corp.
|
Jun 08, 2020 06:02PM
|
